Amundi - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.

Quarter-by-quarter ownership
Amundi ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$44,879,609
+6.5%
1,612,055
+17.5%
0.02%
+4.8%
Q2 2023$42,143,948
+12.5%
1,372,320
+32.9%
0.02%
+5.0%
Q1 2023$37,455,486
+11.1%
1,032,685
+4.3%
0.02%
+11.1%
Q4 2022$33,725,043
-2.6%
990,276
+19.4%
0.02%
-14.3%
Q3 2022$34,620,000
-14.4%
829,606
-11.4%
0.02%
-34.4%
Q2 2022$40,441,000
+230.2%
936,566
+212.2%
0.03%
+300.0%
Q1 2022$12,248,000
+52.6%
299,977
+50.2%
0.01%
+60.0%
Q4 2021$8,025,000
-84.1%
199,723
-85.7%
0.01%
-85.7%
Q3 2021$50,353,000
-56.6%
1,393,281
-50.7%
0.04%
-56.8%
Q2 2021$115,929,0002,828,2650.08%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2022
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders